A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)
Rosenbaum, Evan, Qin, Li-Xuan, Thornton, Katherine Anne, Movva, Sujana, Nacev, Benjamin Alexander, Dickson, Mark Andrew, Gounder, Mrinal M., Keohan, Mary Louise, Avutu, Viswatej, Chi, Ping, Kelly, Ciara Marie, Chan, Jason Earl, Martindale, Moriah, Adamson, Travis, McKennan, Olivia Robin, Erinjeri, Joseph Patrick, Lefkowitz, Robert A, Tap, William D., D'Angelo, Sandra P.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
Rosenbaum, Evan, Movva, Sujana, Kelly, Ciara Marie, Dickson, Mark Andrew, Keohan, Mary Louise, Gounder, Mrinal M., Thornton, Katherine Anne, Chi, Ping, Chan, Jason Earl, Nacev, Benjamin, Avutu, Viswatej, Biniakewitz, Matthew, McKennan, Olivia Robin, Phelan, Haley, Perez, Silvia, Hwang, Sinchun, Singer, Samuel, Qin, Li-Xuan, Tap, William D., D'Angelo, Sandra P.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article